Related Experiment Videos
[Amniotic AFP concentration in pregnancies with numerical chromosome aberrations]
Geburtshilfe Und Frauenheilkunde
|October 1, 1986
Summary
Amniotic fluid alpha-fetoprotein (AFP) levels are typically lower in pregnancies with chromosomal abnormalities like Down syndrome. Further research is needed to establish clinical significance.
Area of Science:
- Obstetrics and Gynecology
- Prenatal Diagnostics
- Biochemistry
Context:
- Amniotic fluid alpha-fetoprotein (AFP) levels naturally decrease during the second trimester of pregnancy.
- Accurate gestational dating is crucial for interpreting AFP levels.
- Previous studies suggest a correlation between low amniotic fluid AFP and chromosomal abnormalities.
Purpose:
- To investigate amniotic fluid alpha-fetoprotein (AFP) levels in normal pregnancies and compare them to pregnancies with trisomic states.
- To assess the diagnostic potential of AFP in identifying numerical chromosomal aberrations.
Summary:
- A study measured amniotic fluid AFP in 360 normal pregnancies (15-23 weeks gestation), establishing gestational age-specific means and SDs.
- In 25 pregnancies with trisomic states (23 trisomy 21, 2 trisomy 18), 19 showed AFP levels below the control mean.
- While most trisomic cases had AFP levels within 1 SD below the mean, some were above or at the mean, indicating a trend but not definitive diagnostic value.
Impact:
- These findings support the observation of lower amniotic fluid AFP in pregnancies with numerical chromosomal aberrations.
- The study highlights the need for further investigation to determine the clinical utility of AFP in prenatal screening for trisomies.
- Current data do not support making clinical decisions based solely on amniotic fluid AFP levels.